197 related articles for article (PubMed ID: 21911455)
1. FOXO3a-Dependent Mechanism of E1A-Induced Chemosensitization.
Su JL; Cheng X; Yamaguchi H; Chang YW; Hou CF; Lee DF; Ko HW; Hua KT; Wang YN; Hsiao M; Chen PB; Hsu JM; Bast RC; Hortobagyi GN; Hung MC
Cancer Res; 2011 Nov; 71(21):6878-87. PubMed ID: 21911455
[TBL] [Abstract][Full Text] [Related]
2. BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.
Blanchard Z; Paul BT; Craft B; ElShamy WM
Breast Cancer Res; 2015 Jan; 17(1):5. PubMed ID: 25583261
[TBL] [Abstract][Full Text] [Related]
3. A new role of protein phosphatase 2a in adenoviral E1A protein-mediated sensitization to anticancer drug-induced apoptosis in human breast cancer cells.
Liao Y; Hung MC
Cancer Res; 2004 Sep; 64(17):5938-42. PubMed ID: 15342371
[TBL] [Abstract][Full Text] [Related]
4. Dicer Elicits Paclitaxel Chemosensitization and Suppresses Cancer Stemness in Breast Cancer by Repressing AXL.
Chang TY; Chen HA; Chiu CF; Chang YW; Kuo TC; Tseng PC; Wang W; Hung MC; Su JL
Cancer Res; 2016 Jul; 76(13):3916-28. PubMed ID: 27216190
[TBL] [Abstract][Full Text] [Related]
5. Forkhead Box Transcription Factor (FOXO3a) mediates the cytotoxic effect of vernodalin in vitro and inhibits the breast tumor growth in vivo.
Ananda Sadagopan SK; Mohebali N; Looi CY; Hasanpourghadi M; Pandurangan AK; Arya A; Karimian H; Mustafa MR
J Exp Clin Cancer Res; 2015 Dec; 34():147. PubMed ID: 26643256
[TBL] [Abstract][Full Text] [Related]
6. Chemosensitization of HER-2/neu-overexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A.
Ueno NT; Yu D; Hung MC
Oncogene; 1997 Aug; 15(8):953-60. PubMed ID: 9285690
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel suppresses the viability of breast tumor MCF7 cells through the regulation of EF1α and FOXO3a by AMPK signaling.
Kim JH; Lee JO; Kim N; Lee HJ; Lee YW; Kim HI; Kim SJ; Park SH; Kim HS
Int J Oncol; 2015 Nov; 47(5):1874-80. PubMed ID: 26397839
[TBL] [Abstract][Full Text] [Related]
8. E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway.
Ueno NT; Bartholomeusz C; Herrmann JL; Estrov Z; Shao R; Andreeff M; Price J; Paul RW; Anklesaria P; Yu D; Hung MC
Clin Cancer Res; 2000 Jan; 6(1):250-9. PubMed ID: 10656456
[TBL] [Abstract][Full Text] [Related]
9. New oncolytic adenoviruses with hypoxia- and estrogen receptor-regulated replication.
Hernandez-Alcoceba R; Pihalja M; Qian D; Clarke MF
Hum Gene Ther; 2002 Sep; 13(14):1737-50. PubMed ID: 12396626
[TBL] [Abstract][Full Text] [Related]
10. E1A oncogene-induced sensitization of human tumor cells to innate immune defenses and chemotherapy-induced apoptosis in vitro and in vivo.
Cook JL; Miura TA; Iklé DN; Lewis AM; Routes JM
Cancer Res; 2003 Jun; 63(12):3435-43. PubMed ID: 12810682
[TBL] [Abstract][Full Text] [Related]
11. beta1-Integrin-collagen interaction suppresses FoxO3a by the coordination of Akt and PP2A.
Nho RS; Kahm J
J Biol Chem; 2010 May; 285(19):14195-209. PubMed ID: 20223831
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide-induced growth arrest of breast cancer MCF-7 cells involving FOXO3a and IκB kinase β expression and localization.
Liu W; Gong Y; Li H; Jiang G; Zhan S; Liu H; Wu Y
Cancer Biother Radiopharm; 2012 Oct; 27(8):504-12. PubMed ID: 22988968
[TBL] [Abstract][Full Text] [Related]
13. Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis.
Zou Y; Tsai WB; Cheng CJ; Hsu C; Chung YM; Li PC; Lin SH; Hu MC
Breast Cancer Res; 2008; 10(1):R21. PubMed ID: 18312651
[TBL] [Abstract][Full Text] [Related]
14. Novel approaches for chemosensitization of breast cancer cells: the E1A story.
Liao Y; Yu D; Hung MC
Adv Exp Med Biol; 2007; 608():144-69. PubMed ID: 17993239
[TBL] [Abstract][Full Text] [Related]
15. Sperm associated antigen 9 (SPAG9) a promising therapeutic target of ovarian carcinoma.
Jagadish N; Fatima R; Sharma A; Devi S; Suri V; Kumar V; Suri A
Tumour Biol; 2018 May; 40(5):1010428318773652. PubMed ID: 29745297
[TBL] [Abstract][Full Text] [Related]
16. Marine lipopeptide Iturin A inhibits Akt mediated GSK3β and FoxO3a signaling and triggers apoptosis in breast cancer.
Dey G; Bharti R; Dhanarajan G; Das S; Dey KK; Kumar BN; Sen R; Mandal M
Sci Rep; 2015 May; 5():10316. PubMed ID: 25974307
[TBL] [Abstract][Full Text] [Related]
17. Enhanced paclitaxel cytotoxicity and prolonged animal survival rate by a nonviral-mediated systemic delivery of E1A gene in orthotopic xenograft human breast cancer.
Liao Y; Zou YY; Xia WY; Hung MC
Cancer Gene Ther; 2004 Sep; 11(9):594-602. PubMed ID: 15272313
[TBL] [Abstract][Full Text] [Related]
18. Systemic gene therapy in human xenograft tumor models by liposomal delivery of the E1A gene.
Ueno NT; Bartholomeusz C; Xia W; Anklesaria P; Bruckheimer EM; Mebel E; Paul R; Li S; Yo GH; Huang L; Hung MC
Cancer Res; 2002 Nov; 62(22):6712-6. PubMed ID: 12438271
[TBL] [Abstract][Full Text] [Related]
19. FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines.
Sunters A; Fernández de Mattos S; Stahl M; Brosens JJ; Zoumpoulidou G; Saunders CA; Coffer PJ; Medema RH; Coombes RC; Lam EW
J Biol Chem; 2003 Dec; 278(50):49795-805. PubMed ID: 14527951
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosis.
Barreyro FJ; Kobayashi S; Bronk SF; Werneburg NW; Malhi H; Gores GJ
J Biol Chem; 2007 Sep; 282(37):27141-27154. PubMed ID: 17626006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
